​Research and Innovation 2016: Trent Vineyard, Nottingham, 23rd March 2016

An event focussing on how new innovations in Cell Biology and Biologics can be applied to improve the success of drug discovery.

Go to the profile of Curtis Asante
Jan 29, 2016
0
0
Upvote 0 Comment

European Laboratory Research & Innovation Group (ELRIG) conference directors Mike Jowett (Illumina) and Mark Wigglesworth (AstraZeneca) are very pleased to welcome you to the 4th annual Research & Innovation conference and technology symposium.

The theme of this year’s conference is “Back to Biology”. The meeting will bring together world class speakers and leading industry experts who will discuss the challenges and opportunities in developing and applying new thinking across biology to improve the success of drug discovery. The focus of this meeting will be Cell Biology and Biologics applying new innovations in these fields to improve the success of drug discovery.

This conference will have 3 tracks; the first will define new thinking in the area of biopharmaceutical agents and how this area continues to offer important alternative approaches to drug discovery. The second will focus on Stem Cell Biology and how innovations in this space are offering improved models for research. Finally a new track for this year where Cell Biology and Biologics are brought together in Synthetic Biology: Engineering complex biological systems. Following the success of previous meetings, this year, the conference is being expanded to include a complementary technology symposium: Innovative Mass Spectrometry.

The objective of this 1 day conference is to provide a communication, education and networking opportunity for scientists engaged in early-phase drug discovery whether in academia, biotech or industry. This conference will bring world class speakers discussing challenges and opportunities in developing new technologies and the way different organisations meet this challenge by bringing their scientists together.

The Research and Innovation tracks are:

Biopharmaceutical Agents: Innovations from Target to Product
Stem Cell Biology: A Roadmap for a Moving Landscape
Synthetic Biology: Engineering complex biological systems

Technology Symposium track:

Innovative Mass Spectrometry: Cornerstone technology for the “omics” revolution

These scientific sessions have been chosen as they represent major transformative areas for early stage drug discovery. The scientific sessions will be complemented by a poster session, a vendor exhibition with over 35 exhibitors and an Innovation zone.

Please see here for more information.

Go to the profile of Curtis Asante

Curtis Asante

Research Funding , Charity Sector

No comments yet.